| DC67100 |
Cetrorelix
Featured
|
Cetrorelix is a potent gonadotrophin-releasing hormone (GnRH) antagonist. Cetrorelix inhibits the endogenous luteinizing hormone surge during ovarian stimulation. Cetrorelix reduces cyclophosphamide induced ovarian follicular destruction in mice. |
|
| DC67101 |
Ganirelix acetate
Featured
|
Ganirelix acetate is an antagonist of GnRH that competitively antagonizes the gonadotropic GnRH receptor, thereby mutating the pathway and causing rapid and reversible inhibition of gonadotropin (luteinizing hormone LH and follicle stimulating hormone FSH) secretion. Ganirelix Acetate acts by competitively blocking the GnRH receptors on the pituitary gonadotroph and subsequent transduction pathway. It induces a rapid, reversible suppression of gonadotropin secretion. The suppression of pituitary LH secretion by Ganirelix Acetate is more pronounced than that of FSH. |
|
| A449 |
Cofetuzumab Biosimilar(Anti-PTK7 / CCK4 Reference Antibody)
Featured
|
Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab is usually CHO (Chinese Hamster Ovary) cells. |
|
| A450 |
Apamistamab Biosimilar(Anti-PTPRC / CD45 Reference Antibody)
Featured
|
|
|
| A451 |
Novartis patent anti-CD45
Featured
|
|
|
| A452 |
Ntx1088 Biosimilar(Anti-PVR / CD155 Reference Antibody)
Featured
|
|
|
| A453 |
GSK-4381562 Biosimilar(Anti-PVRIG Reference Antibody)
Featured
|
|
|
| A454 |
COM701 Biosimilar(Anti-PVRIG Reference Antibody)
Featured
|
|
|
| A455 |
Foravirumab Biosimilar（Anti-Rabies virus GP Reference Antibody）
Featured
|
Foravirumab (CR4098) is a monoclonal antibody against rabies virus glycoprotein antigenic site III. |
|
| A456 |
Rafivirumab Biosimilar（Anti-Rabies virus GP Reference Antibody）
Featured
|
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails. |
|
| A457 |
Medella patent anti-RAMP-3 Biosimilar（Anti-RAMP3 Reference Antibody）
Featured
|
|
|
| A458 |
19G9 Biosimilar（Anti-RG1 Reference Antibody）
Featured
|
|
|
| A459 |
Elezanumab Biosimilar（Anti-RGMA Reference Antibody）
Featured
|
Elezanumab (ABT-555; AE12-1Y-QL) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway, with an IC50 around 97 pM. Elezanumab promotes neuroregeneration and neuroprotection in neuronal injury and demyelination models binds N-terminal RGMa, blocks BMP signaling and lacks RGMc cross-reactivity. elezanumab has neuroregenerative and neuroprotective activities without impact on iron metabolism. |
|
| A460 |
DISC-0974 Biosimilar（Anti-RGMC / HFE2 Reference Antibody）
Featured
|
|
|
| A461 |
Roledumab Biosimilar（Anti-RHD / CD240d Reference Antibody）
Featured
|
Roledumab (LFB-R593) is a human IgG1-κ antibody targeting RHD/CD240D. Roledumab is expressed by YB2/0 rat hybridoma cells. |
|
| A462 |
LFB Anti-RhD Biosimilar（Anti-RHD / CD240d Reference Antibody）
Featured
|
|
|
| A463 |
Asclepius Technology patent anti-Robo1 CAR Biosimilar（Anti-ROBO1 Reference Antibody）
Featured
|
|
|
| A464 |
Zilovertamab Biosimilar(Anti-ROR1 Reference Antibody)
Featured
|
Zilovertamab (UC-961) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling. |
|
| A465 |
Ozuriftamab Biosimilar(Anti-ROR2 Reference Antibody)
Featured
|
Ozuriftamab is a naked human IgG1 kappa antibody of receptor tyrosine kinase-like orphan receptor 2 ROR2, can be used to synthesis ADC. |
|
| A466 |
Oncomed patent anti-RSPO1 Biosimilar(Anti-RSPO1 Reference Antibody )
Featured
|
|
|
| A467 |
Rosmantuzumab Biosimilar(Anti-RSPO3 Reference Antibody)
Featured
|
Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors. |
|
| A468 |
Palivizumab Biosimilar(Anti-RSV-F Reference Antibody)
Featured
|
Palivizumab (MEDI 493) is a humanized monoclonal antibody against respiratory syncytial virus (RSV). Palivizumab can bind to RSV F protein with a Kd value of 1.4 nM. Palivizumab can prevent respiratory syncytial virus infection in cotton mice. |
|
| A469 |
Motavizumab Biosimilar(Anti-RSV-F Reference Antibody)
Featured
|
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research. |
|
| A470 |
Ozanezumab Biosimilar（Anti-RTN4 / NOGO Reference Antibody）
Featured
|
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research. |
|
| A471 |
Atinumab Biosimilar（Anti-RTN4 / NOGO Reference Antibody）
Featured
|
Atinumab (6A3-IgG4) is an antibody. Teropavimab can be used for the research of spinal cord injury (SCI). |
|
| A472 |
NG-101 Biosimilar（Anti-RTN4 / NOGO Reference Antibody）
Featured
|
|
|
| A473 |
LK-1 Biosimilar(Anti-S100A4 Reference Antibody)
Featured
|
|
|
| A474 |
CDX-0158 Biosimilar(Anti-SCFR / c-Kit / CD117 Reference Antibody)
Featured
|
|
|
| A475 |
LOP628 Biosimilar(Anti-SCFR / c-Kit / CD117 Reference Antibody)
Featured
|
|
|
| A476 |
Wuhan U. patent anti-Nav1.9 Biosimilar（Anti-SCN11a / Nav1.9 Reference Antibody）
Featured
|
|
|
